Prof. MD. Aysun Soysal

International Peer-Reviewed Journal Articles

• Sifat Sharmin, Charles B Malpas, Izanne Roos, Ibrahima Diouf, Raed Alroughani, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, Dana Horakova, Eva K Havrdova, Francesco Patti, Murat Terzi, Cavit Boz, Bassem Yamout, Samia J Khoury, Marco Onofrj, Alessandra Lugaresi, Ayse Altintas, Alexandre Prat, Marc Girard, Pierre Duquette, Maria José Sá, Daniele La Spitaleri, Youssef Sidhom, Riadh Gouider, Saloua Mrabet, Aysun Soysal, Recai Turkoglu, Maria Pia Amato, Yara D Fragoso, Tomas Kalincik. Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registry. Journal of Neurology, Neurosurgery & Psychiatry, 2022 Sep 30: jnnp-2022-329713.

• Izanne Roos, Sifat Sharmin, Charles Malpas, Serkan Ozakbas, Jeannette Lechner-Scott, Suzanne Hodgkinson, Raed Alroughani, Sara Eichau Madueño, Cavit Boz, Anneke van der Walt, Helmut Butzkueven, Katherine Buzzard, Olga Skibina, Matteo Foschi, Francois Grand'Maison, Nevin John, Pierre Grammond, Murat Terzi, Julie Prévost, Michael Barnett, Guy Laureys, Liesbeth Van Hijfte, Jose Luis Sanchez-Menoyo, Yolanda Blanco, Jiwon Oh, Pamela McCombe, Cristina Ramo Tello, Aysun Soysal, Alexandre Prat, Pierre Duquette, Bassem I Yamout, Samia Khoury, Vincent van Pesch, Richard Macdonell, Maria Jose Sa, Mark Slee, Jens Kuhle, Davide Maimone, Daniele LA Spitaleri, Barbara Willekens, Abdallah Al Asmi, Emma Tallantyre, Neil P Robertson, Alasdair Coles, J William L Brown, Tomas Kalincik. Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 2024; 30(9): 1163–1175.

• Esma Nur Kolbaşı, Burcu Ersöz Hüseyinoğlu, Zeynep Özdemir, Zübeyr Bayraktaroğlu, Aysun Soysal. Effectiveness of Intermittent Theta Burst Stimulation to Enhance Upper Extremity Recovery After Stroke: A Pilot Study. Archives of Physical Medicine and Rehabilitation, 2024; 105(10): 1880–1889. doi: 10.1016/j.apmr2024.05.025.

• Simona Toscano, Tim Spelman, Serkan Ozakbas, Raed Alroughani, Clara G Chisari, Salvatore Lo Fermo, Alexandre Prat, Marc Girard, Pierre Duquette, Guillermo Izquierdo, Sara Eichau, Pierre Grammond, Cavit Boz, Tomas Kalincik, Yolanda Blanco, Katherine Buzzard, Olga Skibina, Maria Jose Sa, Anneke van der Walt, Helmut Butzkueven, Murat Terzi, Oliver Gerlach, Francois Grand'Maison, Matteo Foschi, Andrea Surcinelli, Michael Barnett, Alessandra Lugaresi, Marco Onofrj, Bassem Yamout, Samia J Khoury, Julie Prevost, Jeannette Lechner-Scott, Davide Maimone, Maria Pia Amato, Daniele Spitaleri, Vincent Van Pesch, Richard Macdonell, Elisabetta Cartechini, Koen de Gans, Mark Slee, Tamara Castillo-Triviño, Aysun Soysal, Jose Luis Sanchez-Menoyo, Guy Laureys, Liesbeth Van Hijfte, Pamela McCombe, Ayse Altintas, Bianca Weinstock-Guttman, Eduardo Aguera-Morales, Masoud Etemadifar, Cristina Ramo-Tello, Nevin John, Recai Turkoglu, Suzanne Hodgkinson, Sarah Besora, Bart Van Wijmeersch, Ricardo Fernandez-Bolaños, Francesco Patti; MSBase Study Group. First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis. Neurotherapeutics, 2025 Mar; 22(2): e00552. doi: 10.1016/j.neurot.2025.e00552.

• Jannis Müller, Sifat Sharmin, Johannes Lorscheider, Serkan Ozakbas, Rana Karabudak, Dana Horakova, Bianca Weinstock-Guttman, Vahid Shaygannejad, Masoud Etemadifar, Raed Alroughani, Francesco Patti, Sara Eichau, Alexandre Prat, Alessandra Lugaresi, Valentina Tomassini, Allan G Kermode, Maria Pia Amato, Recai Turkoglu, Ayse Altintas, Katherine Buzzard, Aysun Soysal, Anneke van der Walt, Helmut Butzkueven, Yolanda Blanco, Oliver Gerlach, Samia J Khoury, Michael Barnett, Nevin John, Jeannette Lechner-Scott, Matteo Foschi, Andrea Surcinelli, Vincent van Pesch, Julie Prevost, Maria Jose Sa, Davide Maimone, Marie D'hooghe, Stella Hughes, Suzanne Hodgkinson, Chris McGuigan, Elisabetta Cartechini, Bruce Taylor, Daniele Spitaleri, Mark Slee, Pamela McCombe, Bassem Yamout, Pascal Benkert, Jens Kuhle, Ludwig Kappos, Izanne Roos, Tomas Kalincik, MSBase Study Group; Eva Kubala Havrdova, Marc Girard, Pierre Duquette, Marzena Fabis-Pedrini, William M Carroll, Olga Skibina, Riadh Gouider, Saloua Mrabet, Cristina Ramo-Tello, Claudio Solaro, Mario Habek, Bart Van Wijmeersch, Radek Ampapa, Richard Macdonell, Celia Oreja-Guevara, Koen de Gans, Guy Laureys, Jiwon Oh, Justin Garber, Orla Gray, Eduardo Agüera-Morales, Jose Luis Sanchez-Menoyo, Tamara Castillo-Triviño, Nikolaos Grigoriadis, Thor Petersen, Todd A Hardy, Steve Vucic, Stephen Reddel, Sudarshini Ramanathan, Abdullah Al-Asmi, Mihaela Simu, Seyed Mohammad Baghbanian, Dieter Poehlau, Talal Al-Harbi, Juan Ignacio Rojas, Norma Deri, Patrice Lalive, Melissa Cambron, Tunde Csepany, Neil Shuey, Barbara Willekens, Cameron Shaw, Danny Decoo, Jennifer Massey, Özgür Yaldizli, Tobias Derfuss, Cristina Granziera. Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 2025 Apr 14: e250495. doi: 10.1001/jamaneurol.2025.0495.